To assess long-term results of implants (XiVE/Frialit-2 Synchro) in a private periodontal practice according to survival and success rates (biological and technical complications) and to detect possible influencing factors, retrospectively. Implant placement of at least one implant took place 10 years ±6 months before clinical and radiographic re-examination. Incidence of implant loss as main and incidence of mucositis/ peri-implantitis as secondary outcome were detected. Also, patient-related and implant-related influencing factors were determined by regression analyses. 100 patients (59.0% female) with 242 implants were included into analysis. Survival rate was 94.0% (XiVE: 97.7%; Frialit-2-Synchro: 66.7%). Mucositis was found in 77.6% of all patients, moderate/severe peri-implantitis in 16.3%. In logistic regression analyses statistically significant influencing factors for implant loss was implant type (p < 0.001), for mucositis a wider implant diameter (p = 0.0438) and a high modified Plaque Index (p = 0.0253), for peri-implantits number of implants per patient (p = 0.0075) and a wider implant diameter (p = 0.0079). Technical complications were found in 47 implants (19.4%). XiVE implants showed a high survival rate over a 10-year follow-up, on the other hand Frialit-2 Synchro implants had worse survival rates. Success rates regarding biological complications are in line with other implant systems.

中文翻译：

---

私人牙周手术中植入物的生存和成功：一项为期10年的回顾性研究。

根据生存和成功率（生物学和技术并发症）评估私密牙周实践中植入物（XiVE / Frialit-2 Synchro）的长期效果，并回顾性地发现可能的影响因素。在临床和X线检查前至少10年±6个月进行了至少1个植入物的植入。检测到以种植体损失为主要发病率，以粘膜炎/种植体周围炎为主要结果。而且，通过回归分析确定了患者相关和植入物相关的影响因素。分析包括100例242颗种植体的患者（女性占59.0％）。存活率为94.0％（XiVE：97.7％; Frialit-2-Synchro：66.7％）。在所有患者中发现粘膜炎占77.6％，在中/重度种植体周围炎中占16.3％。在逻辑回归分析中，对种植体损失的统计上显着影响因素是种植体类型（p <0.001），对于粘膜炎，种植体直径较大（p = 0.0438）和改良菌斑指数（p = 0.0253），对于种植体周围植入物的数量每个患者（p = 0.0075）和更宽的植入物直径（p = 0.0079）。在47个植入物中发现了技术并发症（19.4％）。XiVE植入物在10年的随访中显示出较高的存活率，而Frialit-2 Synchro植入物的存活率较差。关于生物学并发症的成功率与其他植入系统一致。0075）和更宽的植入物直径（p = 0.0079）。在47个植入物中发现了技术并发症（19.4％）。XiVE植入物在10年的随访中显示出较高的存活率，而Frialit-2 Synchro植入物的存活率较差。关于生物学并发症的成功率与其他植入系统一致。0075）和更宽的植入物直径（p = 0.0079）。在47个植入物中发现了技术并发症（19.4％）。XiVE植入物在10年的随访中显示出较高的存活率，而Frialit-2 Synchro植入物的存活率较差。关于生物学并发症的成功率与其他植入系统一致。